Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 65
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/29/2008
 
First Published:
12/8/2006
1.
Phase III/IV Randomized Study of Risk-Adapted Therapy Comprising Observation Only, Combination Chemotherapy, Radiotherapy, and/or Autologous Stem Cell Transplantation in Younger Patients With Neuroblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV, Phase III
Treatment
Active
21 and under
Other
GPOH-NB2004
EU-20661, NCT00410631
2.
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and under
Other
RET5
NCT00186888
Last Modified:
6/17/2008
 
First Published:
5/23/2006
3.
Phase III Randomized Study of Doxorubicin Hydrochloride, Cyclophosphamide, Vincristine, Etoposide, and Ifosfamide With Versus Without Topotecan Hydrochloride in Patients With Newly Diagnosed Localized Ewing's Sarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Approved-not yet active
50 and under
NCI
COG-AEWS0531
AEWS0531, NCT00334867
Last Modified:
11/30/2006
 
First Published:
9/15/2006
4.
Phase III Randomized Study of Ifosfamide, Vincristine, and Dactinomycin With or Without Doxorubicin in Pediatric Patients With Non-Metastatic Rhabdomyosarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 21
Other
CCLG-EPSSG-RMS-2005
EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457
5.
Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Other
3104000
NCT00437307
Last Modified:
9/18/2008
 
First Published:
7/6/2007
6.
Phase III Study of Response- and Biology-Based Combination Chemotherapy and Surgery With or Without Isotretinoin in Young Patients With Intermediate-Risk Neuroblastoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
12 and under
NCI
COG-ANBL0531
ANBL0531, NCT00499616
7.
Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Pharmaceutical / Industry
KTN32313R
NCT00477282
8.
Hydralazine Valproate for Cervical Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Other
006/027/ICI
NCT00532818
9.
Hydralazine Valproate for Ovarian Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Other
006/028/DDI
NCT00533299
10.
AMR PH GL 2007 CL 001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Pharmaceutical / Industry
AMR PH GL 2007 CL 001
NCT00547651
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute